Trial Profile
A Phase II, Multicenter, Clinical Trial to Evaluate The Efficacy and Safety of Bevacizumab in Recurrent Malignant Glioma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioma
- Focus Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 24 May 2016 New trial record